Viral and Placental Determinants of HIV-1 Subtype C Mother-to-Child Transmission

HIV-1 C 亚型母婴传播的病毒和胎盘决定因素

基本信息

  • 批准号:
    7223672
  • 负责人:
  • 金额:
    $ 9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2007-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal aims to comprehensively describe host and virus biology associated with HIV-1 subtype C (HIV-1C) mother-to-child transmission (MTCT). We hypothesize that HIV-1 C MTCT is a non-stochastic event mediated by both placental and viral determinants. To address this hypothesis, we will: 1) genotype and phenotype vertically transmitted envelope (env) genes, 2) characterize envelope genes isolated from archived placental biopsies, 3) describe the placental environment during MTCT. All experiments will use previously collected samples from a well-characterized cohort of 744 HIV-1 C-infected pregnant Malawian women characterized as nontransmitting (NT), in utero (IU) mother-offspring pairs (MOPs) and intrapartum (IP) MOPs. In a preliminary study, we enumerated HIV-1 C V1 A/2 env diversity in 22 MOPs and found that infants had significantly fewer variants than their mothers and confirmed that HIV env diversity is restricted during MTCT. During the mentored portion of this grant (Specific Aim 1), I will test the hypothesis that restriction is facilitated by specific env genotypes. This will be accomplished by cloning full-length envelope genes to: a) compare V1/V2 loop lengths, b) enumerate putative glycosylation sites, c) pseudotype the cloned env genes against CCR5, CxCR4, CD4hi and CD4lo cells. As an independent investigator, I will focus on ID MTCT and test the hypothesis that the placenta is a unique HIV-1 C compartment. Using a heteroduplex tracking assay, I will compare HIV-1 C env genes from matched peripheral blood, placental blood, placental biopsies, and cord blood (Specific Aim 2). Placental specific variants will be characterized using the methods acquired during the mentored phase. In Specific Aim 3, transmitted and placental specific variants will be psuedotyped against primary placental trophoblasts and Hofbauer cells. Finally, in Specific Aim 4, placental biopsies will be analyzed for HIV-1 C, CCR5, CD4, and CXCR4 expression. The results of this project will provide a comprehensive description of the HIV-1 C envelope genes and the placental environment conducive to in utero HIV-1 C MTCT.
描述(由申请人提供):本提案旨在全面描述与HIV-1亚型C (HIV-1C)母婴传播(MTCT)相关的宿主和病毒生物学。我们假设hiv - 1c MTCT是由胎盘和病毒决定因素介导的非随机事件。为了解决这一假设,我们将:1)基因型和表型垂直传播包膜(env)基因,2)表征从存档的胎盘活检中分离的包膜基因,3)描述MTCT期间的胎盘环境。所有实验将使用先前从744名hiv - 1c感染的马拉维孕妇中收集的样本,这些孕妇的特征为非传播性(NT)、子宫内(IU)母婴对(MOPs)和产内(IP) MOPs。在一项初步研究中,我们在22个MOPs中枚举了HIV-1 C V1 a /2的环境多样性,发现婴儿的变异明显少于母亲,并证实了母婴传播期间HIV环境多样性受到限制。在此资助的指导部分(具体目标1),我将验证特定环境基因型促进限制的假设。这将通过克隆全长包膜基因来完成:a)比较V1/V2环长度,b)枚举假定的糖基化位点,c)克隆的env基因针对CCR5、CxCR4、CD4hi和CD4lo细胞进行假型。作为一名独立研究者,我将专注于ID MTCT,并验证胎盘是一个独特的hiv - 1c隔室的假设。使用异源双工跟踪测定,我将比较来自匹配外周血、胎盘血、胎盘活检和脐带血的hiv - 1c环境基因(特异性目标2)。胎盘特异性变异将使用在指导阶段获得的方法进行表征。在Specific Aim 3中,将对原代胎盘滋养细胞和霍夫鲍尔细胞进行遗传变异和胎盘特异性变异的推测分型。最后,在特异性靶4中,胎盘活检将分析hiv - 1c、CCR5、CD4和CXCR4的表达。该项目的结果将提供一个全面的描述hiv - 1c包膜基因和胎盘环境有利于在子宫内hiv - 1c MTCT。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JESSE J KWIEK其他文献

JESSE J KWIEK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JESSE J KWIEK', 18)}}的其他基金

HIV/ART, low birth weight, and mortality in HIV-exposed uninfected children: a translational mechanistic study
HIV/ART、低出生体重和暴露于 HIV 的未感染儿童的死亡率:一项转化机制研究
  • 批准号:
    10393702
  • 财政年份:
    2021
  • 资助金额:
    $ 9万
  • 项目类别:
HIV/ART, low birth weight, and mortality in HIV-exposed uninfected children: a translational mechanistic study
HIV/ART、低出生体重和暴露于 HIV 的未感染儿童的死亡率:一项转化机制研究
  • 批准号:
    10614479
  • 财政年份:
    2021
  • 资助金额:
    $ 9万
  • 项目类别:
HIV/ART, low birth weight, and mortality in HIV-exposed uninfected children: a translational mechanistic study
HIV/ART、低出生体重和暴露于 HIV 的未感染儿童的死亡率:一项转化机制研究
  • 批准号:
    10258233
  • 财政年份:
    2021
  • 资助金额:
    $ 9万
  • 项目类别:
De novo fatty acid biosynthesis and HIV replication
从头脂肪酸生物合成和 HIV 复制
  • 批准号:
    10190804
  • 财政年份:
    2020
  • 资助金额:
    $ 9万
  • 项目类别:
De novo fatty acid biosynthesis and HIV replication
从头脂肪酸生物合成和 HIV 复制
  • 批准号:
    10082548
  • 财政年份:
    2020
  • 资助金额:
    $ 9万
  • 项目类别:
A Method to Stop HIV Replication:Inhibition of Human Purine Utilizing Proteins
阻止HIV复制的方法:抑制人嘌呤利用蛋白
  • 批准号:
    8457221
  • 财政年份:
    2012
  • 资助金额:
    $ 9万
  • 项目类别:
A Method to Stop HIV Replication:Inhibition of Human Purine Utilizing Proteins
阻止HIV复制的方法:抑制人嘌呤利用蛋白
  • 批准号:
    7984177
  • 财政年份:
    2010
  • 资助金额:
    $ 9万
  • 项目类别:
A Method to Stop HIV Replication:Inhibition of Human Purine Utilizing Proteins
阻止HIV复制的方法:抑制人嘌呤利用蛋白
  • 批准号:
    8468988
  • 财政年份:
    2010
  • 资助金额:
    $ 9万
  • 项目类别:
A Method to Stop HIV Replication:Inhibition of Human Purine Utilizing Proteins
阻止HIV复制的方法:抑制人嘌呤利用蛋白
  • 批准号:
    8075457
  • 财政年份:
    2010
  • 资助金额:
    $ 9万
  • 项目类别:
A Method to Stop HIV Replication:Inhibition of Human Purine Utilizing Proteins
阻止HIV复制的方法:抑制人嘌呤利用蛋白
  • 批准号:
    8272655
  • 财政年份:
    2010
  • 资助金额:
    $ 9万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了